Bunkerhill ECG-EF

by Bunkerhill Health  · Based in United States → — The Long-Horizon AI Agent for Health Systems
Cardiology Emergency Medicine Internal Medicine

Contact sales for pricing details.
Regulatory Status Disclosed

Overview

Bunkerhill Health is a pioneering healthcare technology company dedicated to transforming patient care through the power of artificial intelligence. The company’s mission is to bridge the gap between the potential of AI in healthcare and its reality in clinical practice, turning vast amounts of health system data into actionable insights. Its flagship platform, Carebricks, is a generative AI platform for clinical reasoning and action. Carebricks analyzes structured and unstructured patient data, applies AI-powered reasoning, and automates appropriate next steps across a wide range of clinical and operational workflows. This enables health systems to surface overlooked risks, identify treatment candidates, optimize care pathways, streamline operations, and close costly care gaps without adding to clinician workload. Bunkerhill Health collaborates with a consortium of research institutions, including Stanford, Johns Hopkins, and Harvard, to develop, validate, and commercialize AI algorithms. The Bunkerhill ECG-EF tool is an artificial intelligence algorithm available within the Carebricks platform, designed to detect reduced left ventricular ejection fraction from routine ECGs.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI algorithm to detect reduced Left Ventricular Ejection Fraction (LVEF u2264 40%)
  • Analyzes routine 12-lead ECG data
  • Software-only medical device
  • Integrates with Electronic Medical Records (EMR) or ECG Management Systems (EMS)
  • Part of the Carebricks platform for clinical reasoning and action
  • Aids in early identification of patients at risk for heart failure
  • Non-invasive, rapid, and accessible cardiac diagnostic tool
  • Supports automated clinical workflows

Use Cases

  • Screening for reduced ejection fraction in adults
  • Early identification of heart failure risk
  • Proactive and equitable care delivery
  • Automating clinical operations and improving care delivery at scale
  • Surfacing overlooked cardiovascular risks
  • Closing care gaps in cardiac diagnostics

What Physicians Need to Know

ECG/EKG Analysis Capability
Bunkerhill ECG-EF utilizes AI to analyze routine 12-lead ECGs to detect reduced left ventricular ejection fraction (LVEF ≤40%). This allows for earlier identification of patients at risk of heart failure.
Heart Failure Risk Prediction
The algorithm is specifically designed to identify reduced LVEF, a key indicator of heart failure, from standard ECGs. This supports earlier evaluation and more informed clinical decisions for patients at risk of heart failure.
Cardiac CT/MRI Analysis
While ECG-EF focuses on ECG analysis, Bunkerhill Health also has other FDA-cleared AI algorithms for detecting coronary artery calcium and aortic valve calcium on routine CT scans, as well as for identifying aortic aneurysms.
Cardiac Monitoring Integration
The ECG-EF algorithm is available through the MyoVista Insights AI-ECG Algorithm Marketplace, which integrates third-party algorithms into the MyoVista Insights platform. This platform is device-agnostic and designed to improve clinical efficiency and decision-making.
AHA/ACC Guideline Alignment
The detection of reduced LVEF from a routine ECG supports earlier identification and is expected to result in more effective referral of patients at risk of heart failure, aligning with the goal of improving patient outcomes.
Physician Tip

Bunkerhill ECG-EF provides a non-invasive and accessible method for early identification of patients with reduced ejection fraction using routine 12-lead ECGs. This can help flag high-risk patients sooner, potentially leading to earlier intervention and improved outcomes for heart failure. The integration with platforms like MyoVista Insights allows for seamless incorporation into existing clinical workflows. Consider utilizing this tool for opportunistic screening in patients undergoing ECGs for other reasons to identify potential heart failure risk.

Bunkerhill ECG-EF is available within Bunkerhill's Carebricks platform, which allows for the creation of tailored, AI-powered workflows and automation of next steps, such as notifying care teams and routing referrals. It is also integrated into the MyoVista Insights AI-ECG Algorithm Marketplace, which supports integration with electronic health records through HL7v2 order and results workflows, single sign-on (SSO), and SMART on FHIR. This marketplace aims to provide a commercial pathway for AI-ECG developers to reach clinical users through a recurring, SaaS-based revenue model.

Details

Category Cardiology AI
Pricing Contact sales for pricing details.
DeploymentCloud-native platform (Carebricks) that integrates with existing health system infrastructure like EHRs.
Compliance
BAA AvailableUnknown
HIPAA Compliant Yes AI-estimated
FDA Status Yes AI-estimated
Integrations
EHR Not specified
Specialties Cardiology, Emergency Medicine, Internal Medicine

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2025-09-19K250649 510(k)Bunkerhill ECG-EF

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Bunkerhill ECG-EF

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Bunkerhill ECG-EF.

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

Bunkerhill ECG-EF is an FDA-cleared artificial intelligence (AI) algorithm that detects reduced left ventricular ejection fraction (LVEF), a key indicator of heart failure, using data from routine 12-lead electrocardiograms (ECGs). It works by analyzing ECG data to identify patients at risk of heart failure, enabling earlier identification and more effective referral for further evaluation.
Yes, Bunkerhill ECG-EF received FDA 510(k) clearance on September 19, 2025, for detecting reduced ejection fraction from ECGs. It is listed as a Class 2 medical device. Bunkerhill Health also states that ECG-EF is HIPAA and SOC 2 compliant.
Bunkerhill ECG-EF is available within Bunkerhill's Carebricks platform, which allows health systems to create tailored, AI-powered workflows. These workflows can analyze patient data, surface insights, and automate next steps such as notifying care teams, routing referrals, streamlining prior authorization, and triggering actions in third-party platforms. It can also be integrated into platforms like MyoVista Insights, making it accessible to various healthcare facilities.
Other FDA-cleared AI algorithms for detecting low ejection fraction from ECGs include Anumana's AECG-AI Low Ejection Fraction (LEF) 12-Lead algorithm, Tempus ECG-Low EF, and Eko Low Ejection Fraction Tool (ELEFT). These alternatives also aim to provide early detection of reduced LVEF using AI analysis of ECG data.
The pricing for Bunkerhill ECG-EF is available by quote. AI-ECG assessments using assistive algorithms like Bunkerhill ECG-EF are eligible for Medicare reimbursement under the Hospital Outpatient Prospective Payment System, assigned to Ambulatory Payment Classification (APC) 5734, with a national payment rate of approximately $136 per assessment for 2026.
While Bunkerhill ECG-EF is FDA-cleared, the FDA clearance applies to the specific indication in the FDA record and does not describe how well the device works clinically. The algorithm detects reduced LVEF (≤40%), and while it aids in earlier identification, it is a screening tool and further evaluation with echocardiography, the standard test for EF, may still be necessary.

Related Tools

Stethophone Pro
Sparrow Acoustics
Cardiology AI
Stethophone Pro transforms smartphones into advanced cardiac screening tools, enabling clinicians to capture, interpret, and visualize heart sounds for early detection of cardiovascular diseases.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System, ACUSON Origin ICE Diagnostic Ultrasound System
Siemens Medical Solutions, USA
Cardiology AI
Siemens Healthineers offers advanced AI-powered ultrasound systems, including the ACUSON Origin for comprehensive cardiovascular care and the ACUSON Sequoia for high-performance general imaging with BioAcoustic™ technology.
syngo.via MI Workflows, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, syngo MBF is an intelligent, integrated imaging software that helps address the challenges of interpreting, managing, and sharing complex data from molecular imaging scanners, providing automated workflows and advanced visualization for various clinical applications.
syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System
Siemens Medical Solutions USA
Cardiology AI
Siemens Healthineers offers the ACUSON Sequoia, ACUSON Sequoia Select, and ACUSON Origin ultrasound systems, providing advanced imaging for various medical needs. The Sequoia line focuses on high-resolution imaging with deep penetration and reduced variability, while the AI-powered ACUSON Origin specializes in comprehensive cardiovascular diagnostics and interventions.
R30 Diagnostic Ultrasound System
Samsung Medison Co.
Cardiology AI
The Samsung Medison R30 Diagnostic Ultrasound System is a general-purpose, mobile, software-controlled diagnostic ultrasound system that offers a wide range of imaging capabilities and analysis tools for various clinical applications.

See all Cardiology AI tools →

More from Bunkerhill Health

Bunkerhill Abdominal Aortic Quantification (AAQ)
Bunkerhill Health
Cardiology AI
Bunkerhill AVC
Bunkerhill Health
Cardiology AI
Bunkerhill Health provides a generative AI platform, Carebricks, for clinical reasoning and action, integrating with EHRs to automate workflows and improve patient outcomes.
BunkerHill BMD
Bunkerhill Health
Endocrinology & Metabolic AI
Bunkerhill Contrast AVC
BunkerHill Health
Clinical Decision Support & Reference
Bunkerhill Health offers an AI-powered platform, Carebricks, that provides agentic AI infrastructure for hospitals and health systems, automating clinical reasoning and workflows.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-03 | First Added: 2026-04-17
AI Tool Finder
AI-powered search. Results may not be comprehensive.